CME
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
January 20, 2021
Host: Jennifer W. Carlisle, MD
Guest: Suresh S. Ramalingam, MD
Targeted therapy has revolutionized the treatment of advanced non–small-cell lung cancer (NSCLC) across a broad range of molecular aberrations. The epidermal growth factor receptor (EGF
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!